贝纳利祖马布:带来了变革的风向埃索诺菲尔相关疾病
Stephanie Korn1,2, Eugene R Bleecker3, Arnaud Bourdin4
1Thoraxklinik Heidelberg, Heidelberg, Germany.
The World Allergy Organization journal
|December 29, 2025
概括
贝纳利祖马布有效地通过消耗乙酸细胞来治疗严重的乙酸性喘,从而减少药物使用. 它还已被批准用于多炎的异氨酸性颗粒瘤症,并正在研究其他异氨酸性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘通常呈现出一种eosinophilic表型.
- 干白素-5 (IL-5) 在乙酸细胞发育和呼吸道招募中至关重要.
- 贝纳利祖马布向了埃索诺菲尔细胞上的IL-5受体α (IL-5Rα).
研究的目的:
- 审查本拉利祖马布在严重酸性喘 (SEA) 的疗效和安全性.
- 为了探索本拉利祖马布在其他埃索诺菲尔相关疾病中的作用.
- 要突出本拉利祖马布的作用机制和临床数据.
主要方法:
- 对临床试验数据的审查 (WINDWARD计划,SIROCCO,CALIMA).
- 对现实世界证据研究的分析.
- 检查正在进行的第三阶段研究对其他指示的检查.
主要成果:
- 本拉利祖马布有效地降低了血液和组织中的埃索诺菲尔.
- 在治疗SEA方面已证明有效,允许减少皮质类固醇的使用.
- 已获批准用于SEA和带有多炎的eosinophilic granulomatosis (EGPA);正在进行的研究是针对hypereosinophilic综合征和COPD.
结论:
- 贝纳利祖马布是SEA和EGPA的有价值的治疗选择.
- 它的作用机制导致了显著的乙氨基酸细胞枯竭.
- 进一步的研究正在探索其在其他乙酸性疾病中的潜力.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
593
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
593
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K